A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Public ClinicalTrials.gov record NCT00649025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™ 250/10ug Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (250ug Twice Daily) Alone in SkyePharma HFA pMDI and Flovent® HFA pMDI in Adolescent and Adult Patients With Moderate to Severe Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of two medications in one inhaler. The purpose of this study is to determine how well your asthma is controlled when taking one of the three treatment.
Study identification
- NCT ID
- NCT00649025
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 438 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Sep 30, 2008
- Completion
- Sep 30, 2008
- Last update posted
- Aug 26, 2010
2008
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational site | Scottsdale | Arizona | 85251 | — |
| Investigational Site | Tempe | Arizona | 85282 | — |
| Investigational Site | Encinitas | California | 92024 | — |
| Investigational site | Long Beach | California | 90806 | — |
| Investigational site | Orange | California | 92869 | — |
| Investigational Site | Oldsmar | Florida | 34677 | — |
| Investigational Site | Indianapolis | Indiana | 46208 | — |
| Investigational site | Crestview Hills | Kentucky | 41017 | — |
| Investigational Site | Metarie | Louisiana | 70006 | — |
| Investigational site | North Dartmouth | Massachusetts | 02747 | — |
| Investigational Site | Wellesley Hills | Massachusetts | 02481 | — |
| Investigational site | Elizabeth City | North Carolina | 27909 | — |
| Investigational Site | Akron | Ohio | 44313 | — |
| Investigational site | Cincinnati | Ohio | 45227 | — |
| Investigational Site | Portland | Oregon | 97213 | — |
| Investigational Site | East Providence | Rhode Island | 02914 | — |
| Investigational site | Providence | Rhode Island | 02906 | — |
| Investigational Site | Austin | Texas | 78750 | — |
| Investigational site | El Paso | Texas | 79925 | — |
| Investigational site | Richmond | Virginia | 23229 | — |
| Investigational Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.
Recently updated Asthma trials
Other public records listing Asthma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792395: Ginger's Therapeutic Potential in Asthma Not yet recruiting
- NCT07792330: Asthma Lung Sounds With Wearable Stethoscope Not yet recruiting
- NCT07671001: A Study of Depemokimab in Participants of 6 to 11 Years of Age Recruiting
- NCT07772921: A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma Not yet recruiting
- NCT07444567: Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Recruiting
- NCT01449409: Reduce IDentified UNcontrolled Asthma Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00649025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2010 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00649025 live on ClinicalTrials.gov.